SARAH RICHTER: Open Payments
NPI 1689159709 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 49 payments from 13 companies in 2025. Trend: 2023 $353 · 2024 $759 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $242 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $212 |
| Lilly USA, LLC | 7 | $209 |
| Sumitomo Pharma America, Inc. | 9 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| ViiV Healthcare Company | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| ConvaTec Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $17 |
Products named: JARDIANCE, GEMTESA, ZEPBOUND, Rybelsus, Ozempic, Wegovy, MOUNJARO, CAPLYTA.
Industry payments across TX — which companies pay providers there.
